Literature DB >> 3625198

Reduced growth hormone response to apomorphine in schizophrenic patients with poor premorbid social functioning.

K L Malas, D P van Kammen, E A de Fraites, G M Brown, P W Gold.   

Abstract

The apomorphine-induced growth hormone (GH) response of 16 drug-free schizophrenic patients and nine control subjects were studied. The subgroup of nine patients with poor premorbid psychosocial functioning had a significantly lower GH response than the controls. Additional evidence for state dependent effects is provided.

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3625198     DOI： 10.1007/BF01244352

Source DB:  PubMed          Journal:  J Neural Transm            Impact factor:   3.575


  8 in total

1.  A SENSITIVE DOUBLE ANTIBODY IMMUNOASSAY FOR HUMAN GROWTH HORMONE IN PLASMA.

Authors:  D S SCHALCH; M L PARKER
Journal:  Nature       Date:  1964-09-12       Impact factor: 49.962

2.  Case history data and prognosis in schizophrenia.

Authors:  L PHILLIPS
Journal:  J Nerv Ment Dis       Date:  1953-06       Impact factor: 2.254

Review 3.  Molecular pathology of schizophrenia: more than one disease process?

Authors:  T J Crow
Journal:  Br Med J       Date:  1980-01-12

4.  Hormones, dopamine receptors and schizophrenia.

Authors:  H Y Meltzer; D Busch; V S Fang
Journal:  Psychoneuroendocrinology       Date:  1981       Impact factor: 4.905

5.  Growth hormone and prolactin response to apomorphine in schizophrenia and the major affective disorders. Relation to duration of illness and depressive symptoms.

Authors:  H Y Meltzer; T Kolakowska; V S Fang; L Fogg; A Robertson; R Lewine; M Strahilevitz; D Busch
Journal:  Arch Gen Psychiatry       Date:  1984-05

6.  Hormonal effects of apomorphine in schizophrenia.

Authors:  I N Ferrier; E C Johnstone; T J Crow
Journal:  Br J Psychiatry       Date:  1984-04       Impact factor: 9.319

7.  Postsynaptic supersensitivity in schizophrenia.

Authors:  G N Pandey; D L Garver; C Tamminga; S Ericksen; S I Ali; J M Davis
Journal:  Am J Psychiatry       Date:  1977-05       Impact factor: 18.112

8.  Relationship of psychotic symptom clusters in schizophrenia to neuroleptic treatment and growth hormone response to apomorphine.

Authors:  F P Zemlan; J Hirschowitz; F Sautter; D L Garver
Journal:  Psychiatry Res       Date:  1986-07       Impact factor: 3.222
  8 in total
  1 in total

1.  Dopaminergic, Noradrenergic, Adrenal, and Thyroid Abnormalities in Psychotic and Affective Disorders.

Authors:  Fabrice Duval; Marie-Claude Mokrani; Alexis Erb; Vlad Danila; Felix Gonzalez Lopera; Ludovic Jeanjean
Journal:  Front Psychiatry       Date:  2020-09-18       Impact factor: 4.157
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.